Golden Sun Health (NASDAQ: GSUN) regains Nasdaq listing rule compliance

Rhea-AI Filing Summary

Golden Sun Health Technology Group Limited reported that on August 27, 2025 it received formal notice from Nasdaq that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), the minimum stockholders’ equity requirement for listing on The Nasdaq Capital Market. The company now meets all applicable criteria for continued listing, although Nasdaq will continue to monitor its status and could initiate a new delisting process if future periodic financial statements show that it no longer satisfies the minimum stockholders’ equity rule.

Positive

• Nasdaq compliance restored: The company has regained compliance with Nasdaq Listing Rule 5550(b)(1), removing an active deficiency and supporting continued trading on The Nasdaq Capital Market.

Negative

• None.

Insights

Equity Markets & Listing Standards Analyst

Golden Sun Health has regained compliance with Nasdaq’s equity listing rule, reducing immediate delisting risk.

Nasdaq notified Golden Sun Health Technology Group Limited on August 27, 2025 that the company now satisfies Listing Rule 5550(b)(1), the minimum stockholders’ equity standard for The Nasdaq Capital Market. This means the company currently meets all applicable criteria for continued trading on that market tier, removing an active deficiency status.

Maintaining an exchange listing can be important for liquidity and investor access, so curing a stockholders’ equity shortfall is generally viewed as a favorable development. However, Nasdaq stated it will keep monitoring compliance with the Minimum Stockholders’ Equity Rule, and if a future periodic financial filing shows the requirement is not met, a new delisting process could begin, with potential appeal rights to a hearings panel.

Overall, this update signals that earlier equity concerns have been addressed sufficiently for Nasdaq’s standards at this time, while underscoring that ongoing financial performance and balance sheet levels will determine whether the company remains in compliance in future reporting periods.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of August 2025

Commission File Number: 001-41425

金太阳健康科技集团有限公司

(Translation of registrant’s name into English)

Golden Sun Health Technology Group Limited

Room 503, Building C2, No. 1599

Xinjinqiao Road, Pudong New Area

Shanghai, China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INCORPORATION BY REFERENCE

This Current Report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form F-1, as amended (Registration Number: 333-285857) of Golden Sun Health Technology Group Limited, a Cayman Islands exempted company (the “Company”), declared effective by the Securities and Exchange Commission (“SEC”) on March 25, 2025 (“Registration Statement”), and into each prospectus or prospectus supplement outstanding under the Registration Statement, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

On August 27, 2025, the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has evidenced compliance with Nasdaq Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Rule”) and all other applicable criteria for continued listing on The Nasdaq Capital Market. Nasdaq will continue to monitor the Company to ensure its ongoing compliance with the Minimum Stockholders’ Equity Rule and, if at the time of the filing of the Company’s next periodic financial statements the Company does not evidence compliance with the Minimum Stockholders’ Equity Rule, the Company may again be subject to delisting. In such event, the Staff would provide written notice of the deficiency the Company, which the Company may appeal to a Nasdaq Hearings Panel.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Golden Sun Health Technology Group Limited
	By:	/s/ Xueyuan Weng
		Name:	Xueyuan Weng
		Title:	Chief Executive Officer

Date: August 29, 2025

2

FAQ

What did Golden Sun Health Technology Group Limited (GSUN) announce in this report?

The company disclosed that on August 27, 2025 it received formal notice from Nasdaq that it has evidenced compliance with Nasdaq Listing Rule 5550(b)(1), the minimum stockholders’ equity requirement, and now meets all applicable criteria for continued listing on The Nasdaq Capital Market.

What is Nasdaq Listing Rule 5550(b)(1) mentioned for GSUN?

Nasdaq Listing Rule 5550(b)(1) is referred to as the Minimum Stockholders’ Equity Rule. The notice confirms that Golden Sun Health currently meets this stockholders’ equity standard required to remain listed on The Nasdaq Capital Market.

Is Golden Sun Health still at risk of Nasdaq delisting after regaining compliance?

Yes, there is still potential risk. Nasdaq will continue to monitor Golden Sun Health’s compliance with the Minimum Stockholders’ Equity Rule, and if the company’s next periodic financial statements do not show compliance, it may again become subject to delisting procedures, with the possibility to appeal to a Nasdaq Hearings Panel.

Does this Nasdaq notice mean GSUN’s listing on The Nasdaq Capital Market is secure?

The notice confirms that Golden Sun Health currently satisfies all applicable criteria for continued listing on The Nasdaq Capital Market. However, future non-compliance with the minimum stockholders’ equity requirement, as reflected in upcoming periodic financial statements, could restart a delisting process.

What options would Golden Sun Health have if Nasdaq initiates a new delisting process?

If, after reviewing a future periodic financial statement, Nasdaq finds Golden Sun Health no longer complies with the Minimum Stockholders’ Equity Rule, the staff would send written notice of deficiency. The company would then have the ability to appeal to a Nasdaq Hearings Panel.

How is this Form 6-K related to Golden Sun Health’s existing registration statement?

The report states that this Form 6-K is deemed incorporated by reference into Golden Sun Health’s Form F-1 registration statement (No. 333-285857) and related prospectuses, except where later filings may supersede it.